Clinical Trial Update: The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating the efficacy of different antiviral drugs in patients with SARS-CoV infection and COVID-19, with unclear current status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome
• Sars-cov Infection

Snippet

Sponsor: Oslo University Hospital | Conditions: SARS-CoV Infection, COVID 19 | Phase 2, Phase 3 | Status: UNKNOWN